News Quantified

NBIX – neurocrine biosciences, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Neurocrine Biosciences (NBIX) was upgraded by Zacks Research from "strong sell" to "hold".

How Investors May Respond To Neurocrine Biosciences (NBIX) INGREZZA Real-World Persistence Edge Over AUSTEDO XR [Yahoo! Finance]

Is It Time To Reassess Neurocrine Biosciences (NBIX) After Its Recent Share Price Pullback? [Yahoo! Finance]

Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2026 Financial Results [Yahoo! Finance]

Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2026 Financial Results [TheStreet.com]

-10.4%

BEAT

-6.4%

BEAT

-6.2%

BEAT

8.4%

BEAT

Canaccord Genuity

Form DEFA14A NEUROCRINE BIOSCIENCES

Form ARS NEUROCRINE BIOSCIENCES For: Dec 31

Form DEF 14A NEUROCRINE BIOSCIENCES For: Apr 15

Form 8-K NEUROCRINE BIOSCIENCES For: Apr 05

Form SCHEDULE 13G/A NEUROCRINE BIOSCIENCES Filed by: VANGUARD GROUP INC

Top News Gainers

7/29 Q2/2019 6/30/2019 EPS 0.540 ZacksConsensus 0.270 ActVsEst 0.270 - Beat 10.3%

11/8 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 7.4%

5/29 Form 4 NEUROCRINE BIOSCIENCES For: May 24 Filed by: Bozigian Haig P. 5.2%

3/25 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 4.6%

4/17 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 3.9%

8/8 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 3.6%

10/16 Form 4 NEUROCRINE BIOSCIENCES For: Oct 14 Filed by: Lloyd-Smith Malcolm 3.3%

7/8 Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2019 Financial Results 3.2%

5/7 Neurocrine Biosciences to Present at Bank of America Merrill Lynch Health Care Conference 2019 3.0%

1/28 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 3.0%

Top News Decliners

1/10 Form 4 NEUROCRINE BIOSCIENCES For: Jan 08 Filed by: ROBERTS EIRY -8.1%

7/31 Form 4 NEUROCRINE BIOSCIENCES For: Jul 30 Filed by: Bozigian Haig P. -4.5%

4/30 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "buy" rating re-affirmed by analysts at William Blair. -3.8%

2/24 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is now covered by analysts at William Blair. They set an "outperform" rating on the stock. -3.8%

6/4 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is now covered by analysts at Guggenheim. They set a "neutral" rating on the stock. -3.7%

5/17 Form 3 NEUROCRINE BIOSCIENCES For: May 07 Filed by: Cooke Julie -3.3%

4/30 Form 4 NEUROCRINE BIOSCIENCES For: Apr 28 Filed by: ABERNETHY MATT -3.3%

4/27 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC. -3.0%

2/4 Q4/2019 12/31/2019 EPS 1.050 ZacksConsensus 0.820 ActVsEst 0.230 - Beat -2.9%

8/8 Form 4 NEUROCRINE BIOSCIENCES For: Aug 06 Filed by: GORMAN KEVIN CHARLES -2.4%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day